MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in MiNK Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +4 vs. Q1 2026
- Shares held
- 204.4K
- +77.6K (+61.2%) vs. Q1 2026
- Total value
- $2.39M
- +$1.05M (+78.9%) vs. Q1 2026
- New holders
- 7
- 6 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jones Financial Companies LLLP | 1 | $12 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2 | $23 | 0.00% | +2 | New |
| LifeSteps Financial, Inc. | 2 | $23 | 0.00% | +2 | New |
| Key Financial Inc | 4 | $47 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9 | $107 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 13 | $152 | 0.00% | −3−18.8% | Reduced |
| Clearstead Advisors, LLC | 14 | $164 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 16 | $187 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 18 | $210 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 18 | $210 | 0.00% | +8+80.0% | Added |
| Barclays PLC | 24 | $281 | 0.00% | +24 | New |
| Covestor Ltd | 119 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 113 | $1.32K | 0.00% | +9+8.7% | Added |
| Advisor Group Holdings, Inc. | 117 | $1.37K | 0.00% | +116+11,600.0% | Added |
| Tower Research Capital LLC (TRC) | 422 | $4.93K | 0.00% | +266+170.5% | Added |
| Federation des caisses Desjardins du Quebec | 500 | $5.84K | 0.00% | +500 | New |
| Paladin Partners, LLC | 1,000 | $11.7K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 1,995 | $23.3K | 0.00% | +1,995 | New |
| Steward Partners Investment Advisory, LLC | 2,000 | $23.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,885 | $57.1K | 0.00% | −10,317−67.9% | Reduced |
| Vanguard Fiduciary Trust Co | 8,287 | $96.9K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 13,382 | $156.4K | 0.00% | +7,179+115.7% | Added |
| Citadel Advisors LLC | 15,440 | $180.5K | 0.00% | +15,440 | New |
| Geode Capital Management, LLC | 15,573 | $182.1K | 0.00% | −1,772−10.2% | Reduced |
| Longbow Finance SA | 16,667 | $194.8K | 0.02% | 00.0% | Unchanged |
| DnB Asset Management AS | 55,142 | $644.6K | 0.00% | +55,142 | New |
| Vanguard Capital Management LLC | 68,660 | $802.6K | 0.00% | +9,296+15.7% | Added |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −91−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |